Increased Active Metabolite Formation Explains the Greater Platelet Inhibition With Prasugrel Compared to High-dose Clopidogrel-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Increased Active Metabolite Formation Explains the Greater Platelet Inhibition With Prasugrel Compared to High-dose Clopidogrel

Published:2007-11 Issue:5 Volume:50 Page:555-562
ISSN:0160-2446
Container-title:Journal of Cardiovascular Pharmacology
language:en
Short-container-title:

Author:

Payne Christopher D,Li Ying Grace,Small David S,Ernest C Steven,Farid Nagy A,Jakubowski Joseph A,Brandt John T,Salazar Daniel E,Winters Kenneth J

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine,Pharmacology

Reference43 articles.

1. Platelets in atherothrombosis.;Ruggeri;Nat Med,2002

2. Atherothrombosis and high risk plaque. I. Evolving concepts.;Fuster;J Am Coll Cardiol,2005

3. International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis.;Bhatt;JAMA,2006

4. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation.;N Engl J Med,2001

5. Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial.;Chen;Lancet,2005

Cited by 155 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical pharmacology of selatogrel for self-administration by patients with suspected acute myocardial infarction;Expert Opinion on Drug Metabolism & Toxicology;2023-10-03

2. Antiplatelet Drugs for Neurointerventions: Part 2 Clinical Applications;Clinical Neuroradiology;2021-03-01

3. Pharmacokinetics and Pharmacodynamics of Approved and Investigational P2Y12 Receptor Antagonists;Clinical Pharmacokinetics;2020-02-13

4. Aspirin in the primary prevention of cardiovascular disease in diabetes mellitus: A new perspective;Diabetes Research and Clinical Practice;2020-02

5. Oral antiplatelet agents in cardiovascular disease;Vasa;2019-07-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3